Literature DB >> 25435660

Treating femoropopliteal disease: established and emerging technologies.

Athanasios Diamantopoulos1, Konstantinos Katsanos1.   

Abstract

The femoropopliteal artery is the most common site of disease in patients with peripheral arterial disease and presents some of the greatest challenges for interventional radiology. Many patients can be managed with medical treatment combined with supervised exercise alone. However, a significant proportion, especially those suffering from severe intermittent claudication or critical limb ischemia, will require some form of endovascular or surgical revascularization procedure. During the past few years an endovascular-first approach has gained support from all vascular specialties. Today, even complex lesions can be treated successfully with an endovascular approach. Unfortunately, the unique bio-mechanical properties of this vascular segment have limited long-term patency rates and clinical value of the endovascular options. In this review, the authors discuss the methods and techniques for treatment of femoropopliteal lesions and review the current evidence for commercially available devices on patency outcomes following successful recanalization.

Entities:  

Keywords:  angioplasty; balloon; covered stent; drug-eluting; femoropopliteal; interventional radiology; paclitaxel-coated; restenosis; severe leg ischemia; stent; subintimal

Year:  2014        PMID: 25435660      PMCID: PMC4232427          DOI: 10.1055/s-0034-1393971

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  29 in total

1.  Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation.

Authors:  A Bolia; J Brennan; P R Bell
Journal:  Clin Radiol       Date:  1989-05       Impact factor: 2.350

Review 2.  What is the evidence for the efficacy of cryoplasty?

Authors:  D O Kessel; R H Samson
Journal:  J Cardiovasc Surg (Torino)       Date:  2008-04       Impact factor: 1.888

3.  Endovascular treatment of femoral-popliteal disease.

Authors:  Adam Ryan Geronemus; Constantino S Peña
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

4.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

5.  Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.

Authors:  Konstantinos Katsanos; Gunnar Tepe; Dimitris Tsetis; Fabrizio Fanelli
Journal:  Cardiovasc Intervent Radiol       Date:  2014-04-11       Impact factor: 2.740

6.  Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.

Authors:  Martin Werner; Antonio Micari; Angelo Cioppa; Giuseppe Vadalà; Andrej Schmidt; Horst Sievert; Paolo Rubino; Annalisa Angelini; Dierk Scheinert; Giancarlo Biamino
Journal:  JACC Cardiovasc Interv       Date:  2014-02-13       Impact factor: 11.195

7.  Paclitaxel-coated balloons and aneurysm formation in peripheral vessels.

Authors:  Athanasios Diamantopoulos; Yuri Gupta; Hany Zayed; Konstantinos Katsanos
Journal:  J Vasc Surg       Date:  2014-05-05       Impact factor: 4.268

8.  Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.

Authors:  Salvatore Cassese; Robert A Byrne; Ilka Ott; Gjin Ndrepepa; Mateja Nerad; Adnan Kastrati; Massimiliano Fusaro
Journal:  Circ Cardiovasc Interv       Date:  2012-07-31       Impact factor: 6.546

Review 9.  2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Vasc Surg       Date:  2011-09-29       Impact factor: 4.268

Review 10.  Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review.

Authors:  Rosemarie Met; Krijn P Van Lienden; Mark J W Koelemay; Shandra Bipat; Dink A Legemate; Jim A Reekers
Journal:  Cardiovasc Intervent Radiol       Date:  2008-04-15       Impact factor: 2.740

View more
  7 in total

Review 1.  Endovascular treatment of femoro-popliteal lesions.

Authors:  Aman Kansal; Chandler A Long; Manesh R Patel; W Schuyler Jones
Journal:  Clin Cardiol       Date:  2018-12-04       Impact factor: 2.882

2.  FAK Activation Promotes SMC Dedifferentiation via Increased DNA Methylation in Contractile Genes.

Authors:  Kyuho Jeong; James M Murphy; Jung-Hyun Kim; Pamela Moore Campbell; Hyeonsoo Park; Yelitza A R Rodriguez; Chung-Sik Choi; Jun-Sub Kim; Sangwon Park; Hyun Joon Kim; Jonathan G Scammell; David S Weber; Richard E Honkanen; David D Schlaepfer; Eun-Young Erin Ahn; Ssang-Taek Steve Lim
Journal:  Circ Res       Date:  2021-10-27       Impact factor: 17.367

Review 3.  Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

Authors:  Konstantinos Katsanos; Benjamin P Geisler; Abigail M Garner; Hany Zayed; Trevor Cleveland; Jan B Pietzsch
Journal:  BMJ Open       Date:  2016-05-09       Impact factor: 2.692

4.  BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.

Authors:  Benjamin D Hunt; Matthew A Popplewell; Huw Davies; Lewis Meecham; Hugh Jarrett; Gareth Bate; Margaret Grant; Smitaa Patel; Catherine Hewitt; Lazaros Andronis; Jonathan J Deeks; Andrew Bradbury
Journal:  Trials       Date:  2017-05-19       Impact factor: 2.279

5.  Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries.

Authors:  Konstantinos Katsanos; Said A M Al-Lamki; Aneeta Parthipun; Stavros Spiliopoulos; Sanjay Dhanji Patel; Ioannis Paraskevopoulos; Hany Zayed; Athanasios Diamantopoulos
Journal:  Cardiovasc Intervent Radiol       Date:  2016-12-05       Impact factor: 2.740

Review 6.  Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment.

Authors:  Timothy M Sullivan; Thomas Zeller; Masato Nakamura; Colin G Caro; Michael Lichtenberg
Journal:  Int J Vasc Med       Date:  2018-02-26

7.  Improving the Outcomes of Complex Lesions of the Femoropopliteal Artery Using Atherectomy and Drug Coated Balloon.

Authors:  Sangmin Kim
Journal:  Korean Circ J       Date:  2022-02       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.